Clinical risk factors associated with malignancy in TIF1-γ(+) dermatomyositis

被引：0
|
作者：
Cassard, L. [1 ,2 ]
Flatley, E. [2 ,4 ]
Fernandez, A. P. [2 ,3 ]
机构：
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH USA
[2] Cleveland Clin, Dermatol, Cleveland, OH USA
[3] Cleveland Clin, Pathol, Cleveland, OH USA
[4] Rutgers State Univ, Robert Wood Johnson Med Sch, Newark, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
152
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [1] CLINICAL RISK FACTORS ASSOCIATED WITH MALIGNANCY IN TIF1-γ(+) DERMATOMYOSITIS PATIENTS
    Cassard, Lydia A.
    Flatley, Elizabeth M.
    Fernandez, Anthony P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 559 - 559
  • [2] Characteristic vascular finding in TIF1-γ dermatomyositis
    Franciosi, Ellen
    Houk, Laura
    Rashighi, Mehdi
    BMJ CASE REPORTS, 2021, 14 (01)
  • [3] Salt and pepper dyspigmentation in dermatomyositis with TIF1-γ autoantibodies
    Svigos, K.
    Gutierrez, D.
    Femia, A.
    Brinster, N. K.
    Lo Sicco, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S98 - S98
  • [4] Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
    Harada, Yumi
    Tominaga, Masaki
    Iitoh, Eriko
    Kaieda, Shinjiro
    Koga, Takuma
    Fujimoto, Kiminori
    Chikasue, Tomonori
    Obara, Hitoshi
    Kakuma, Tatsuyuki
    Ida, Hiroaki
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [5] Clinical features of anti-transcription intermediary factor 1γ (TIF1γ)-positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer-associated dermatomyositis
    Motegi, Sei-ichiro
    Sekiguchi, Akiko
    Ikeuchi, Hidekazu
    Sakairi, Toru
    Ogawa, Hiroomi
    Fujii, Takaaki
    Sohda, Makoto
    Yajima, Toshiki
    Ida, Shota
    Takayasu, Yukihiro
    Shimoda, Yuki
    Hiromura, Keiju
    Saeki, Hiroshi
    Shirabe, Ken
    Chikamatsu, Kazuaki
    Yokoo, Hideaki
    Oyama, Tetsunari
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2020, 47 (12): : 1395 - 1402
  • [6] Histopathological risk factors for malignancy in dermatomyositis
    Pruessmann, Wiebke
    Kleinheinz, Andreas
    Zillikens, Detlef
    Rose, Christian
    HISTOPATHOLOGY, 2022, 81 (04) : 529 - 535
  • [7] TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report
    Yuan, Zhu
    Chen, Chunyan
    Zeng, Shuai
    Wang, Zhen
    Zhong, Shili
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 3915 - 3920
  • [8] TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients
    Nguyen, Huong D.
    Jouen, Fabienne
    Dechelotte, Benoit
    Cordel, Nadege
    Gitiaux, Cyril
    Bodemer, Christine
    Quartier, Pierre
    Belot, Alexandre
    O'Brien, Kathryn
    Cancemi, Dario
    Melki, Isabelle
    Fabien, Nicole
    Tansley, Sarah
    Boyer, Olivier
    Wedderburn, Lucy R.
    Bader-Meunier, Brigitte
    RHEUMATOLOGY, 2024, 63 (10) : e281 - e284
  • [9] Increase in Mitochondrial Mass of Lymphocyte Subsets in Anti-MDA5 and TIF1-γ-Positive Dermatomyositis Patients
    Li, Xiaomeng
    Ma, Qingqing
    Huang, Yuan
    Cheng, Linlin
    Liu, Yongmei
    Li, Haolong
    Zhan, Haoting
    Zhang, Fengchun
    Liu, Yudong
    Li, Yongzhe
    IMMUNOLOGICAL INVESTIGATIONS, 2024, 53 (08) : 1381 - 1396
  • [10] Clinical and biological factors predictive of malignancy in dermatomyositis
    Prohic, A.
    Kasumagic-Halilovic, E.
    Simic, D.
    Selmanagic, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 591 - 592
12345